Join MedCity News and nearly 300 healthcare investors, startups, and innovative-minded executives in Chicago at the Ritz Carlton on May 21-22 for MedCity INVEST 2024. The conference is the premier boutique healthcare investment event in the U.S. Equal parts networking and curated panels covering the latest healthcare investment trends, GLP-1 drugs, women’s health, and more, MedCity INVEST 2024 is the ideal event to discuss healthcare funding with investors looking for investment opportunities.
Here’s a preview of a few of the panels:
Women’s Health Sector Matures
May 22, 2:35 pm Central Time
In 2024, there’s a welcome shift in investors finally giving women’s health the attention it deserves. While past investments concentrated on obstetrics/gynecology platforms and fertility services, there’s now a gradual diversification. Investors are expanding their interests in women’s health to encompass primary care, mental health, wellness, and various other services. Although pregnancy, fertility, and menopause remain substantial areas of investment, we are entering the next phase of advancing women’s health.
Employers Embrace Value-Based Care
May 21, 3:35 pm, Central Time
Employers are jumping on value-based care for a number of reasons: VBC aligns with their goals of controlling costs, improving employee health outcomes, enhancing satisfaction, and ensuring the long-term sustainability of their workforce. Hear from prominent employers and their service providers about employer-focused VBC strategies.
Investment Trends in Healthcare
May 21, 1:35 pm, Central Time
Fewer deals, slower investment pace, smaller check sizes, more deal scrutiny and more pragmatic valuations. That is the current reality of investing in healthcare innovation. Paradoxically, does this scenario imply that superior startups are securing funding, increasing the likelihood of them achieving profitability? Gain insights from influential investors as they discuss trends in the healthcare investment arena.
Among the speakers confirmed for the conference are:
Kenneth Nelson, Partner, MedTech Advantage Fund
Jasmi Shah, Senior Vice President, Chief Health & Wellness Officer, Delta
Jack Stockert MD, Managing Diector, Health 2047
Dr. Rekha Kumar, Chief Medical Officer, Weill Cornell Medical College
Nirdesh Gupta, Managing Director, Cedars-Sinai Medical Center
Jane Rho, Director, Fund & AI, DaVita Ventures, Davita
Photo: Rawpixel, Getty Images
